Position in FTRE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,569,261
+$5,263,271 QoQ
Shares Held
607,429
+7.8% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 334 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. FTRE ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in FTRE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,569,261 | 607,429 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $5,305,990 | 563,269 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,005,032 | 580,002 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,877,862 | 579,319 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $3,077,602 | 622,997 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $4,196,346 | 555,808 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $11,042,121 | 592,071 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $13,090,300 | 654,515 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $15,820,267 | 677,818 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $26,729,663 | 665,911 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $25,448,097 | 729,172 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $18,793,976 | 657,362 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $394,447 | 11,598 | Shares | Other | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||